A panel of gene expression biomarkers predicting sustained virologic response (SVR) in chronic hepatitis C patients (CH-C) treated with pegylated interferon alpha and ribavirin

被引：0
|
作者：
Younossi, Z. M. [1 ]
Baranova, A. [1 ]
Stepanova, M. [1 ]
Afendy, A. [1 ]
Wheeler, A. [1 ]
Hossain, N. [1 ]
Bakshi, A. [1 ]
Santini, C. D. [2 ]
Sigua, C. L. [2 ]
Chan, J. [2 ]
Iverson, A. A. [2 ]
Chang, S. P. [2 ]
机构：
[1] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA
[2] Celera, Alameda, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60768-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
766
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [1] PROTEIN PATHWAY BIOMARKERS PREDICTING SUSTAINED VIROLOGIC RESPONSE (SVR)TO PEGYLATED INTERFERON (PEG-IFN) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C (CH-C)
    Younossi, Z.
    Limongi, D.
    Stepanova, M.
    Pierobon, M.
    Afendy, A.
    Liotta, L.
    Petricoin, E.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S420 - S420
  • [2] Gene expression biomarkers predicting response to pegylated interferon alpha (PEGIFN) and ribavirin (RBV) in treatment-name patients with chronic hepatitis C (CH-C)
    Younossi, Zobair M.
    Collantes, Rochelle
    Baronova, Ancha
    Bakshi, Anita
    Steponova, Maria
    Manyam, Ganiroju
    Santini, Chris
    Siqua, Chris
    Chan, Joanne
    Iverson, Ayuko
    Chang, Sheng-Yung
    HEPATOLOGY, 2007, 46 (04) : 357A - 357A
  • [3] Protein Pathway Biomarkers Predicting Sustained Virologic Response (SVR) to Pegylated Interferon (PEG-IFN) and Ribavirin (RBV) in Treatment-Naive Genotype 1 Patients With Chronic Hepatitis C (Ch-C)
    Limongi, Dolores
    Stepanova, Maria
    Afendy, Arian
    Pierobon, Mariaelena
    Agrawal, Ritambhara
    Liotta, Lance
    Petricoin, Emanuel
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2010, 138 (05) : S783 - S783
  • [4] Rapid Virologic Response Predicts Sustained Virologic Response in Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin Therapy
    Sarwar, Shahzad
    Iqbal, Masood
    McCormick, P. Aiden
    O'Farrelly, Cliona
    Hegarty, John E.
    GASTROENTEROLOGY, 2009, 136 (05) : A836 - A837
  • [5] AKT ACTIVATION IS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR) AFTER TREATMENT WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PEG-IFN plus RBV) IN PATIENTS WITH CHRONIC HEPATITIS C (CH-C)
    Birerdinc, Aybike
    Stepanova, Maria
    Limongi, Dolores
    Afendy, Arian
    Pierobon, Mariaelena
    Younossi, Issah
    Liotta, Lance
    Baranova, Ancha
    Petricoin, Emanuel F.
    Younossi, Zobair M.
    HEPATOLOGY, 2010, 52 (04) : 728A - 728A
  • [6] Gene expression biomarkers predicting response to pegylated interferon alpha (PEG-IFN) and ribavirin (RBV) in the peripheral blood of patients with chronic hepatitis C (CH-C), non-responder (NR) to previous treatment
    Younossi, Zobair M.
    Collantes, Rochelle
    Baranova, Ancha
    Kim, Amy
    Manyam, Ganiraju
    Stepanova, Maria
    Santini, Chris
    Sigua, Chris
    Chan, Joanne
    Iverson, Ayuko
    Chang, Sheng-Yung
    HEPATOLOGY, 2007, 46 (04) : 389A - 389A
  • [7] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Paci, M.
    Lorefice, E.
    Gianni, E.
    Renzo, S.
    Capanni, M.
    Forte, P.
    Milani, S.
    Surrenti, C.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113
  • [8] Immunological biomarkers of virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Menezes, E.
    Reis, J.
    Cardoso, L.
    Teixeira Carvalho, A.
    Filho, A. M. O.
    Teixeira, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1269 - 1269
  • [9] Early predictors of sustained viral response (SVR) in chronic hepatitis C (Genotype 4) patients treated with pegylated interferon alpha-2a and ribavirin
    Elmakhzangy, HI
    Rekacewicz, C
    Shouman, S
    Mohamed, HN
    Esmat, G
    Mansour, AA
    Ismail, A
    Rafaat, R
    Elhosseiny, M
    Eldaly, M
    Elkafrawy, S
    Abdel-Hamid, M
    Fontanet, A
    Pol, S
    Mohamed, MK
    GASTROENTEROLOGY, 2005, 128 (04) : A714 - A714
  • [10] Gene expression profiles of patients with chronic hepatitis C (CH-C) treated with pegylated interferon alfa-2b and ribavirin (PEG-IFN/RBV)
    Younossi, ZM
    Chan, J
    Schlauch, K
    Assmann, J
    Santini, C
    Ong, J
    Martin, L
    Gramlich, T
    McAllister, L
    Chang, SY
    GASTROENTEROLOGY, 2004, 126 (04) : A719 - A720
12345